Randomized Controlled Trial of Oral Vancomycin Treatment in Clostridioides difficile-Colonized Patients
Skye R. S. Fishbein, Tiffany Hink, Kimberly A. Reske, Candice Cass, Emily Struttmann, Zainab Hassan Iqbal, Sondra Seiler, Jennie H. Kwon, Carey‐Ann D. Burnham, Gautam Dantas, Erik R. Dubberke
Abstract
A gold standard diagnostic for Clostridioides difficile infection (CDI) does not exist. An area of controversy is how to manage patients whose stool tests positive by nucleic acid amplification tests but negative by toxin enzyme immunoassay.
Topics & Concepts
ClostridioidesGold standard (test)VancomycinRandomized controlled trialMedicineInternal medicineImmunoassayNucleic Acid Amplification TestsAntibioticsMicrobiologyIntensive care medicineGastroenterologyBiologyVirologyImmunologyBacteriaStaphylococcus aureusGeneticsChlamydia trachomatisAntibodyClostridium difficile and Clostridium perfringens researchMicroscopic ColitisAntimicrobial Resistance in Staphylococcus